41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 16-19 December 2001

9 January 2002. Related: Conference reports, Conference index, ICAAC 41st Chicago 2001.

Report from the conference.

• Low dose pegylated interferon is ineffective in treating HIV/HCV co-infected patients

• Phenotypic resistance to ddI is less frequent than resistance to ZDV, 3TC and abacavir

• Impact of Kaletra on amprenavir plasma concentrations in HIV treatment-experienced patients

• Immune reconstitution more difficult with low baseline CD4+ T cell counts

• HIV-1 may revert to less pathogenic strain a few days after starting HAART

• Change from CCR5 to CXCR4 phenotype may affect immunologic responses

• ddI EC (Videx) study confirms and clarifies dosing on an empty stomach

• Swatch study: should we be cycling drugs?

• New HIV drugs, resistance, pharmacogenomics

• Antiretroviral therapy

• Immunopathogenesis of HIV infection